Key terms

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest AFMD news

Apr 04 11:03am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 01 7:26am ET Affimed price target raised to $5 from $1 at Stifel by TipRanks Apr 01 7:19am ET Truist Financial Sticks to Its Buy Rating for Affimed (AFMD) by TipRanks Apr 01 6:26am ET Promising Clinical Trials and Strategic Financial Management Affirm Buy Rating for Affimed by TipRanks Apr 01 6:22am ET Affimed price target raised to $10 from $5 at H.C. Wainwright by TipRanks Mar 31 10:20pm ET Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Atara Biotherapeutics (ATRA) by TipRanks Mar 31 4:12pm ET Affimed price target lowered to $25 from $30 at Wells Fargo by TipRanks Mar 31 11:05am ET Buy Rating Affirmed on Affimed: Promising Clinical Outlook and Robust Financial Position by TipRanks Mar 28 9:27pm ET Affimed Therapeutics’ Optimistic Clinical Outlook by TipRanks Mar 08 7:50pm ET Affimed NV trading halted, news pending by TipRanks Mar 06 6:33am ET Affimed announces 1-for-10 reverse stock split by TipRanks Jan 08 4:16pm ET Affimed provides update on AFM24-102 Trial in EGFR-wildtype NSCLC by TipRanks Jan 08 8:19am ET Affimed announces strategic restructuring, reducing headcount by 50% by TipRanks Jan 08 8:18am ET Affimed CEO Adi Hoess to step down by TipRanks

No recent press releases are available for AFMD

AFMD Financials

1-year income & revenue

Key terms

AFMD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AFMD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments